SCHEMBL19690491

SCHEMBL19690491

CCOC(=O)C1(C(=O)OCC)N=C(c2ccccc2)N=C1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
OPRM1 P35372 3/20 0.39
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
SLC22A1 O15245 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663302 0.78 ALOX5 (0.40) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL18663265 0.71 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL11200738 0.69 TSHR (0.42) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL9416753 0.68 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL18663303 0.68 CACNA1D (0.39) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL9416778 0.66 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
Biphenyl SCHEMBL5571790 0.65 TSHR (0.54) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL26862448 0.65 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
Biphenyl SCHEMBL927814 0.64 MEN1 (0.67) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1
SCHEMBL6315068 0.64 OPRM1 (0.40) SMN1; SMN2ALDH1A1HPGDKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2019-06-06 US disclosed
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, GTF2I, POF1B SMN1; SMN2 1503/4885ALDH1A1 2055/4885HPGD 2103/4885
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, COG7, COG4 SMN1; SMN2 3127/4885ALDH1A1 2496/4885HPGD 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.